Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose–effect meta-analysis.

Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose–effect meta-analysis – The British Journal of Psychiatry

Commentary on Twitter

Low-doses of aripiprazole [2-5 mg] as augmentation treatment for depression might achieve the optimal balance between efficacy, tolerability and acceptability, per this meta-analysis (certainty of evidence low to moderate)https://t.co/aTkcQOsORp

— Awais Aftab (@awaisaftab) November 21, 2021